These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4291066)

  • 21. Significance of a newly identified attenuating mutation in Sabin 3 oral poliovirus vaccine.
    Mento SJ; Weeks-Levy C; Tatem JM; Gorgacz EJ; Waterfield WF
    Dev Biol Stand; 1993; 78():93-9; discussion 99-100. PubMed ID: 8388835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transgenic mice as an alternative to monkeys for neurovirulence testing of live oral poliovirus vaccine: validation by a WHO collaborative study.
    Dragunsky E; Nomura T; Karpinski K; Furesz J; Wood DJ; Pervikov Y; Abe S; Kurata T; Vanloocke O; Karganova G; Taffs R; Heath A; Ivshina A; Levenbook I
    Bull World Health Organ; 2003; 81(4):251-60. PubMed ID: 12764491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transgenic mice carrying the human poliovirus receptor: new animal models for study of poliovirus neurovirulence.
    Horie H; Koike S; Kurata T; Sato-Yoshida Y; Ise I; Ota Y; Abe S; Hioki K; Kato H; Taya C
    J Virol; 1994 Feb; 68(2):681-8. PubMed ID: 8289371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New approaches to oral poliovirus vaccine neurovirulence tests: transgenic mice susceptible to poliovirus and molecular analysis of poliovirus. A meeting report of the WHO Global Programme for Vaccines and Immunization and the WHO Biologicals Unit, Geneva, Switzerland, 26-28 September 1996.
    Vaccine; 1997 Mar; 15(4):341-5. PubMed ID: 9141201
    [No Abstract]   [Full Text] [Related]  

  • 25. Development of candidates for new type 2 and type 3 oral poliovirus vaccines.
    Kohara M; Abe S; Yoshioka I; Nomoto A
    Dev Biol Stand; 1993; 78():141-8. PubMed ID: 8388824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Neurovirulence of a new attenuated poliovirus type 3 (USOL-D) in a monkey experiment].
    Unterharnscheidt F; Simon J
    Naturwissenschaften; 1965 Sep; 52(17):502. PubMed ID: 4956397
    [No Abstract]   [Full Text] [Related]  

  • 27. Evidence on the safety and efficacy of live poliomyelitis vaccines currently in use, with special reference to type 3 poliovirus.
    Bull World Health Organ; 1969; 40(6):925-45. PubMed ID: 4310724
    [No Abstract]   [Full Text] [Related]  

  • 28. New assays for the quality control of live oral poliovirus vaccine.
    Furesz J; Levenbook I
    Acta Microbiol Immunol Hung; 1998; 45(3-4):391-9. PubMed ID: 9873944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a transgenic mouse neurovirulence test for oral poliovirus vaccine: international collaborative study 1993-1999.
    Levenbook I; Dragunsky E; Pervikovc Y
    Vaccine; 2000 Sep; 19(2-3):163-6. PubMed ID: 10930668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experience in Canada with the new revised monkey neurovirulence test for oral poliovirus vaccine.
    Contreras G; Furesz J; Karpinski K; Grinwich K; Gardell C
    J Biol Stand; 1988 Jul; 16(3):195-205. PubMed ID: 2844825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the neurovirulence test of oral poliovaccines in Japan during the period 1963-1982.
    Chino F; Kodama H; Hara M; Komatsu T
    Jpn J Med Sci Biol; 1984; 37(5-6):233-40. PubMed ID: 6536783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurovirulence tests of type 3 oral poliovirus vaccine manufactured by Lederle Laboratories, 1964-1988.
    Nathanson N; Horn SD
    Vaccine; 1992; 10(7):469-74. PubMed ID: 1609550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [ON THE DETERMINATION OF THE NEUROVIRULENCE OF LIVE POLIOVIRUS VACCINES. II. PATHOMORPHOLOGY OF APE POLIOMYELITIS CAUSED BY ATTENUATED POLIOVIRUSES AFTER INTRALUMBAR INJECTION WITH SPECIAL REFERENCE TO DIFFERENCES BETWEEN THE VIRUS TYPES].
    UNTERHARNSCHEIDT F; BONIN O
    Arch Psychiatr Nervenkr; 1965 Mar; 206():454-73. PubMed ID: 14271779
    [No Abstract]   [Full Text] [Related]  

  • 34. Bilateral substantia nigra involvement in vaccine-associated poliomyelitis.
    França MC; Schmutzler KM; Garibaldi SG; Zanardi VA; Nucci A
    Neurology; 2006 May; 66(10):1597-8. PubMed ID: 16717231
    [No Abstract]   [Full Text] [Related]  

  • 35. A poliomyelitis model through mucosal infection in transgenic mice bearing human poliovirus receptor, TgPVR21.
    Nagata N; Iwasaki T; Ami Y; Sato Y; Hatano I; Harashima A; Suzaki Y; Yoshii T; Hashikawa T; Sata T; Horiuchi Y; Koike S; Kurata T; Nomoto A
    Virology; 2004 Mar; 321(1):87-100. PubMed ID: 15033568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preliminary studies on the neurovirulence of poliomyelitis vaccine (oral) prepared in vero cells.
    Guo R; Chen SF; Luo GX; Luo QS; Xu QF
    Proc Chin Acad Med Sci Peking Union Med Coll; 1988; 3(2):104-7. PubMed ID: 2848237
    [No Abstract]   [Full Text] [Related]  

  • 37. Investigation of type 3 poliovirus variants with increased L-cystine-dependence as live vaccines.
    Elbert LB; Chumakov MP; Krutyanskaya GL; Ralph NM; Tyufanov AV; Sokolova IS; Alpatova GA
    Arch Gesamte Virusforsch; 1971; 33(3):259-70. PubMed ID: 4329636
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of serial passage on Sabin oral poliomyelitis vaccine virus in secondary monkey kidney versus Vero cells as measured by the monkey neurovirulence test.
    Dommann CJ
    J Med Primatol; 1994 Sep; 23(7):388-92. PubMed ID: 7731028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis.
    Pliaka V; Kyriakopoulou Z; Markoulatos P
    Expert Rev Vaccines; 2012 May; 11(5):609-28. PubMed ID: 22827246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccine-related paralytic poliomyelitis in an immunodeficient child.
    Feigin RD; Guggenheim MA; Johnsen SD
    J Pediatr; 1971 Oct; 79(4):642-7. PubMed ID: 4106164
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.